Medidur fluocinolone acetonide intravitreal implant: Completed Phase III enrollment

pSivida completed enrollment of 150 patients in a double-blind, sham-controlled, Indian Phase III trial

Read the full 141 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE